share_log

Recent 6.8% Pullback Isn't Enough to Hurt Long-term Cross Country Healthcare (NASDAQ:CCRN) Shareholders, They're Still up 106% Over 3 Years

Recent 6.8% Pullback Isn't Enough to Hurt Long-term Cross Country Healthcare (NASDAQ:CCRN) Shareholders, They're Still up 106% Over 3 Years

最近6.8%的回调不足以伤害长期的越野医疗保健(纳斯达克股票代码:CCRN)股东,他们在3年内仍上涨了106%
Simply Wall St ·  02/09 09:12

Cross Country Healthcare, Inc. (NASDAQ:CCRN) shareholders have seen the share price descend 12% over the month. But that doesn't change the fact that the returns over the last three years have been very strong. Indeed, the share price is up a very strong 106% in that time. After a run like that some may not be surprised to see prices moderate. If the business can perform well for years to come, then the recent drop could be an opportunity.

Cross Country Healthcare, Inc.(纳斯达克股票代码:CCRN)的股东本月股价下跌了12%。但这并不能改变过去三年的回报非常强劲的事实。事实上,当时股价强劲上涨了106%。在这样的上涨之后,有些人看到价格适中可能并不感到惊讶。如果该业务能够在未来几年内表现良好,那么最近的下跌可能是一个机会。

While this past week has detracted from the company's three-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

尽管过去一周减损了该公司的三年回报率,但让我们来看看基础业务的最新趋势,看看涨幅是否一致。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

尽管一些人继续教导高效市场假说,但事实证明,市场是反应过度的动态系统,投资者并不总是理性的。研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。

During three years of share price growth, Cross Country Healthcare moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here.

在三年的股价增长中,Cross Country Healthcare从亏损转为盈利。正如我们在这里看到的那样,这种转变可能是一个转折点,可以证明股价的强劲上涨是合理的。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

该公司的每股收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-per-share-growth
NasdaqGS:CCRN Earnings Per Share Growth February 9th 2024
纳斯达克GS:CCRN每股收益增长 2024年2月9日

We know that Cross Country Healthcare has improved its bottom line over the last three years, but what does the future have in store? Take a more thorough look at Cross Country Healthcare's financial health with this free report on its balance sheet.

我们知道Cross Country Healthcare在过去三年中提高了利润,但是未来会怎样?通过这份免费的资产负债表报告,更全面地了解Cross Country Healthcare的财务状况。

A Different Perspective

不同的视角

Investors in Cross Country Healthcare had a tough year, with a total loss of 22%, against a market gain of about 22%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 15%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand Cross Country Healthcare better, we need to consider many other factors. For example, we've discovered 3 warning signs for Cross Country Healthcare (1 can't be ignored!) that you should be aware of before investing here.

Cross Country Healthcare的投资者经历了艰难的一年,总亏损了22%,而市场涨幅约为22%。即使是优质股票的股价有时也会下跌,但我们希望在过于感兴趣之前看到企业基本指标的改善。长期投资者不会那么沮丧,因为他们本可以在五年内每年赚取15%的收入。如果基本面数据继续显示长期可持续增长,那么当前的抛售可能是一个值得考虑的机会。长期追踪股价表现总是很有意思的。但是,要更好地了解越野医疗保健,我们需要考虑许多其他因素。例如,我们发现了 Cross Country Healthcare 的 3 个警告信号(1 个不容忽视!)在这里投资之前,您应该注意这一点。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你想与管理层一起购买股票,那么你可能会喜欢这份免费的公司名单。(提示:业内人士一直在购买它们)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发